Cost effectiveness and strategic planning (WHO-CHOICE)

WHO-CHOICE Interventions

Tuberculosis


CODE DESCRIPTION COVERAGE
TB-1 SmearPos: Treatment of new smear-positive cases only under DOTS 50%
TB-2 SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS 50%
TB-3 SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR 50%
TB-4 Combination: As SmearPos, plus DOTS treatment of smear-negative cases plus DOTS-plus standardized second-line drug re-treatment as defined in Intervention 3 50%
TB-5 SmearPos: Treatment of new smear-positive cases only under DOTS 80%
TB-6 SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS 80%
TB-7 SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR 80%
TB-8 Combination: As SmearPos, plus DOTS treatment of smear-negative cases plus DOTS-plus standardized second-line drug re-treatment as defined in Intervention 3 80%
TB-9 SmearPos: Treatment of new smear-positive cases only under DOTS 95%
TB-10 SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS 95%
TB-11 SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR 95%
TB-12 Combination: As SmearPos, plus DOTS treatment of smear-negative cases plus DOTS-plus standardized second-line drug re-treatment as defined in Intervention 3 95%
Share